InvestorsHub Logo
Followers 1
Posts 183
Boards Moderated 0
Alias Born 07/30/2014

Re: norman22 post# 22729

Friday, 09/26/2014 7:52:08 PM

Friday, September 26, 2014 7:52:08 PM

Post# of 48316
stormin normin, its just not about the mice data. it's about how the mice data correlates with the data from the phase 2 human trial. if they can make a solid presumption or hypothesis with data supporting turning non responders into responders then that imo would be enough to move the stock price. The key is to have solid data from both mice and patient to support their hypothesis. eom